25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Clinical Laserthermia Systems AB (publ)
Buy, Hold or Sell?

Let's analyze Clinical Laserthermia Systems AB (publ) together

I guess you are interested in Clinical Laserthermia Systems AB (publ). Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Clinical Laserthermia Systems AB (publ). At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Clinical Laserthermia Systems AB (publ)

I send you an email if I find something interesting about Clinical Laserthermia Systems AB (publ).

1. Quick Overview

1.1. Quick analysis of Clinical Laserthermia Systems AB (publ) (30 sec.)










1.2. What can you expect buying and holding a share of Clinical Laserthermia Systems AB (publ)? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
kr4.18
Expected worth in 1 year
kr3.91
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
kr-0.27
Return On Investment
-6.0%

For what price can you sell your share?

Current Price per Share
kr4.50
Expected price per share
kr0 - kr6.4
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Clinical Laserthermia Systems AB (publ) (5 min.)




Live pricePrice per Share (EOD)
kr4.50
Intrinsic Value Per Share
kr-43.39 - kr-8.04
Total Value Per Share
kr-39.21 - kr-3.86

2.2. Growth of Clinical Laserthermia Systems AB (publ) (5 min.)




Is Clinical Laserthermia Systems AB (publ) growing?

Current yearPrevious yearGrowGrow %
How rich?$5.2m$1.3m$2.9m68.5%

How much money is Clinical Laserthermia Systems AB (publ) making?

Current yearPrevious yearGrowGrow %
Making money-$1.4m-$1.4m-$16k-1.1%
Net Profit Margin-360.7%-1,499.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Clinical Laserthermia Systems AB (publ) (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Clinical Laserthermia Systems AB (publ)?

Welcome investor! Clinical Laserthermia Systems AB (publ)'s management wants to use your money to grow the business. In return you get a share of Clinical Laserthermia Systems AB (publ).

First you should know what it really means to hold a share of Clinical Laserthermia Systems AB (publ). And how you can make/lose money.

Speculation

The Price per Share of Clinical Laserthermia Systems AB (publ) is kr4.5. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Clinical Laserthermia Systems AB (publ).
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Clinical Laserthermia Systems AB (publ), you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr4.18. Based on the TTM, the Book Value Change Per Share is kr-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.72 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Clinical Laserthermia Systems AB (publ).

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.08-1.9%-0.10-2.3%-0.10-2.1%-0.10-2.3%-0.07-1.6%
Usd Book Value Change Per Share0.132.8%-0.01-0.1%0.071.5%0.010.3%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.020.4%0.000.1%0.000.0%
Usd Total Gains Per Share0.132.8%-0.01-0.1%0.081.8%0.020.3%0.010.2%
Usd Price Per Share0.48-0.26-0.06-0.32-0.67-
Price to Earnings Ratio-1.41--0.75--0.17--0.91--4.80-
Price-to-Total Gains Ratio3.79--1.34--1.91--3.45-1.27-
Price to Book Ratio1.26-0.87-1.93--6.36--0.49-
Price-to-Total Gains Ratio3.79--1.34--1.91--3.45-1.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.40815
Number of shares2450
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.01
Usd Total Gains Per Share-0.010.02
Gains per Quarter (2450 shares)-15.0637.94
Gains per Year (2450 shares)-60.23151.77
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-60-7034118142
20-120-13067236294
30-181-190101354446
40-241-250135472598
50-301-310168591750
60-361-370202709902
70-422-4302368271054
80-482-4902699451206
90-542-55030310631358
100-602-61033611811510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%1.063.00.01.6%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%6.014.00.030.0%13.027.00.032.5%22.042.00.034.4%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.039.02.5%1.00.063.01.6%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%6.014.00.030.0%13.027.00.032.5%22.042.00.034.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Clinical Laserthermia Systems AB (publ) compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.389-0.068+105%0.722+92%0.133+945%0.074+1774%
Book Value Per Share--4.1793.381+24%1.064+293%1.887+121%2.117+97%
Current Ratio--3.1142.184+43%1.376+126%1.315+137%2.425+28%
Debt To Asset Ratio--0.1500.239-37%0.803-81%0.608-75%0.408-63%
Debt To Equity Ratio--0.1680.311-46%3.220-95%6.557-97%3.435-95%
Dividend Per Share----0%0.189-100%0.038-100%0.019-100%
Eps---0.931-1.152+24%-1.053+13%-1.149+23%-0.816-12%
Free Cash Flow Per Share---0.871-1.139+31%-1.510+73%-1.120+29%-0.826-5%
Free Cash Flow To Equity Per Share--0.401-0.228+157%-0.082+121%0.090+343%0.070+475%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---8.043--------
Intrinsic Value_10Y_min---43.393--------
Intrinsic Value_1Y_max---2.945--------
Intrinsic Value_1Y_min---4.635--------
Intrinsic Value_3Y_max---7.219--------
Intrinsic Value_3Y_min---13.760--------
Intrinsic Value_5Y_max---9.528--------
Intrinsic Value_5Y_min---22.634--------
Market Cap62679150.000-17%73264962.00039987183.798+83%8861090.723+727%48912018.001+50%102509658.060-29%
Net Profit Margin---2.397-3.607+50%-14.996+526%-1244.443+51814%-844.008+35109%
Operating Margin---2.326-3.621+56%-11.848+409%-1099.988+47181%-771.624+33067%
Operating Ratio--2.7195.620-52%13.266-80%1142.163-100%839.993-100%
Pb Ratio1.077-17%1.2590.869+45%1.933-35%-6.362+605%-0.491+139%
Pe Ratio-1.209+14%-1.413-0.748-47%-0.172-88%-0.906-36%-4.803+240%
Price Per Share4.500-17%5.2602.871+83%0.636+727%3.512+50%7.360-29%
Price To Free Cash Flow Ratio-1.292+14%-1.510-0.718-52%-0.104-93%1.218-224%-8.126+438%
Price To Total Gains Ratio3.240-17%3.787-1.342+135%-1.911+150%-3.446+191%1.273+198%
Quick Ratio--2.2921.538+49%1.172+96%1.322+73%2.546-10%
Return On Assets---0.189-0.264+40%-0.327+73%-0.282+49%-0.222+17%
Return On Equity---0.212-0.334+57%-1.474+595%-2.322+994%-1.268+498%
Total Gains Per Share--1.389-0.068+105%0.912+52%0.171+713%0.093+1393%
Usd Book Value--5279012.1004271629.875+24%1344151.325+293%2383772.865+121%2674225.049+97%
Usd Book Value Change Per Share--0.126-0.006+105%0.066+92%0.012+945%0.007+1774%
Usd Book Value Per Share--0.3790.307+24%0.097+293%0.171+121%0.192+97%
Usd Dividend Per Share----0%0.017-100%0.003-100%0.002-100%
Usd Eps---0.084-0.105+24%-0.095+13%-0.104+23%-0.074-12%
Usd Free Cash Flow---1100281.700-1438819.450+31%-1907509.183+73%-1414524.952+29%-1043139.045-5%
Usd Free Cash Flow Per Share---0.079-0.103+31%-0.137+73%-0.102+29%-0.075-5%
Usd Free Cash Flow To Equity Per Share--0.036-0.021+157%-0.007+121%0.008+343%0.006+475%
Usd Market Cap5684998.905-17%6645132.0533626837.571+83%803700.929+727%4436320.033+50%9297625.986-29%
Usd Price Per Share0.408-17%0.4770.260+83%0.058+727%0.318+50%0.668-29%
Usd Profit---1176016.200-1455803.025+24%-1439771.800+22%-1475008.750+25%-1042870.044-11%
Usd Revenue--490596.300422367.225+16%183939.600+167%146970.280+234%135316.439+263%
Usd Total Gains Per Share--0.126-0.006+105%0.083+52%0.015+713%0.008+1393%
 EOD+2 -6MRQTTM+31 -2YOY+32 -35Y+31 -410Y+20 -15

3.3 Fundamental Score

Let's check the fundamental score of Clinical Laserthermia Systems AB (publ) based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.209
Price to Book Ratio (EOD)Between0-11.077
Net Profit Margin (MRQ)Greater than0-2.397
Operating Margin (MRQ)Greater than0-2.326
Quick Ratio (MRQ)Greater than12.292
Current Ratio (MRQ)Greater than13.114
Debt to Asset Ratio (MRQ)Less than10.150
Debt to Equity Ratio (MRQ)Less than10.168
Return on Equity (MRQ)Greater than0.15-0.212
Return on Assets (MRQ)Greater than0.05-0.189
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Clinical Laserthermia Systems AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.351
Ma 20Greater thanMa 504.604
Ma 50Greater thanMa 1004.910
Ma 100Greater thanMa 2005.223
OpenGreater thanClose3.820
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Clinical Laserthermia Systems AB (publ)

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.

Fundamental data was last updated by Penke on 2024-11-14 17:36:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Clinical Laserthermia Systems AB (publ) earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Clinical Laserthermia Systems AB (publ) to the Medical Devices industry mean.
  • A Net Profit Margin of -239.7% means that kr-2.40 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Clinical Laserthermia Systems AB (publ):

  • The MRQ is -239.7%. The company is making a huge loss. -2
  • The TTM is -360.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-239.7%TTM-360.7%+121.0%
TTM-360.7%YOY-1,499.6%+1,138.9%
TTM-360.7%5Y-124,444.3%+124,083.6%
5Y-124,444.3%10Y-84,400.8%-40,043.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-239.7%-6.4%-233.3%
TTM-360.7%-15.3%-345.4%
YOY-1,499.6%-15.2%-1,484.4%
5Y-124,444.3%-18.1%-124,426.2%
10Y-84,400.8%-23.4%-84,377.4%
4.3.1.2. Return on Assets

Shows how efficient Clinical Laserthermia Systems AB (publ) is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Clinical Laserthermia Systems AB (publ) to the Medical Devices industry mean.
  • -18.9% Return on Assets means that Clinical Laserthermia Systems AB (publ) generated kr-0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Clinical Laserthermia Systems AB (publ):

  • The MRQ is -18.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -26.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.9%TTM-26.4%+7.5%
TTM-26.4%YOY-32.7%+6.3%
TTM-26.4%5Y-28.2%+1.7%
5Y-28.2%10Y-22.2%-6.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.9%-2.1%-16.8%
TTM-26.4%-3.2%-23.2%
YOY-32.7%-4.0%-28.7%
5Y-28.2%-3.0%-25.2%
10Y-22.2%-4.1%-18.1%
4.3.1.3. Return on Equity

Shows how efficient Clinical Laserthermia Systems AB (publ) is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Clinical Laserthermia Systems AB (publ) to the Medical Devices industry mean.
  • -21.2% Return on Equity means Clinical Laserthermia Systems AB (publ) generated kr-0.21 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Clinical Laserthermia Systems AB (publ):

  • The MRQ is -21.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -33.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.2%TTM-33.4%+12.1%
TTM-33.4%YOY-147.4%+114.1%
TTM-33.4%5Y-232.2%+198.8%
5Y-232.2%10Y-126.8%-105.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.2%-2.4%-18.8%
TTM-33.4%-3.8%-29.6%
YOY-147.4%-4.2%-143.2%
5Y-232.2%-4.4%-227.8%
10Y-126.8%-5.7%-121.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Clinical Laserthermia Systems AB (publ).

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Clinical Laserthermia Systems AB (publ) is operating .

  • Measures how much profit Clinical Laserthermia Systems AB (publ) makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Clinical Laserthermia Systems AB (publ) to the Medical Devices industry mean.
  • An Operating Margin of -232.6% means the company generated kr-2.33  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Clinical Laserthermia Systems AB (publ):

  • The MRQ is -232.6%. The company is operating very inefficient. -2
  • The TTM is -362.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-232.6%TTM-362.1%+129.4%
TTM-362.1%YOY-1,184.8%+822.7%
TTM-362.1%5Y-109,998.8%+109,636.7%
5Y-109,998.8%10Y-77,162.4%-32,836.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-232.6%-10.8%-221.8%
TTM-362.1%-16.8%-345.3%
YOY-1,184.8%-13.0%-1,171.8%
5Y-109,998.8%-17.4%-109,981.4%
10Y-77,162.4%-19.8%-77,142.6%
4.3.2.2. Operating Ratio

Measures how efficient Clinical Laserthermia Systems AB (publ) is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 2.72 means that the operating costs are kr2.72 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Clinical Laserthermia Systems AB (publ):

  • The MRQ is 2.719. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.620. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.719TTM5.620-2.902
TTM5.620YOY13.266-7.646
TTM5.6205Y1,142.163-1,136.543
5Y1,142.16310Y839.993+302.170
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7191.324+1.395
TTM5.6201.340+4.280
YOY13.2661.326+11.940
5Y1,142.1631.373+1,140.790
10Y839.9931.321+838.672
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Clinical Laserthermia Systems AB (publ).

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Clinical Laserthermia Systems AB (publ) is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.11 means the company has kr3.11 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Clinical Laserthermia Systems AB (publ):

  • The MRQ is 3.114. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.184. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.114TTM2.184+0.930
TTM2.184YOY1.376+0.807
TTM2.1845Y1.315+0.869
5Y1.31510Y2.425-1.110
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1142.573+0.541
TTM2.1842.666-0.482
YOY1.3762.922-1.546
5Y1.3153.393-2.078
10Y2.4253.470-1.045
4.4.3.2. Quick Ratio

Measures if Clinical Laserthermia Systems AB (publ) is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Clinical Laserthermia Systems AB (publ) to the Medical Devices industry mean.
  • A Quick Ratio of 2.29 means the company can pay off kr2.29 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Clinical Laserthermia Systems AB (publ):

  • The MRQ is 2.292. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.538. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.292TTM1.538+0.754
TTM1.538YOY1.172+0.365
TTM1.5385Y1.322+0.216
5Y1.32210Y2.546-1.224
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2921.528+0.764
TTM1.5381.698-0.160
YOY1.1721.875-0.703
5Y1.3222.296-0.974
10Y2.5462.545+0.001
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Clinical Laserthermia Systems AB (publ).

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Clinical Laserthermia Systems AB (publ) assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Clinical Laserthermia Systems AB (publ) to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.15 means that Clinical Laserthermia Systems AB (publ) assets are financed with 15.0% credit (debt) and the remaining percentage (100% - 15.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Clinical Laserthermia Systems AB (publ):

  • The MRQ is 0.150. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.239. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.150TTM0.239-0.089
TTM0.239YOY0.803-0.564
TTM0.2395Y0.608-0.369
5Y0.60810Y0.408+0.200
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1500.407-0.257
TTM0.2390.398-0.159
YOY0.8030.360+0.443
5Y0.6080.437+0.171
10Y0.4080.457-0.049
4.5.4.2. Debt to Equity Ratio

Measures if Clinical Laserthermia Systems AB (publ) is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Clinical Laserthermia Systems AB (publ) to the Medical Devices industry mean.
  • A Debt to Equity ratio of 16.8% means that company has kr0.17 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Clinical Laserthermia Systems AB (publ):

  • The MRQ is 0.168. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.311. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.168TTM0.311-0.143
TTM0.311YOY3.220-2.909
TTM0.3115Y6.557-6.246
5Y6.55710Y3.435+3.122
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1680.552-0.384
TTM0.3110.589-0.278
YOY3.2200.530+2.690
5Y6.5570.630+5.927
10Y3.4350.698+2.737
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Clinical Laserthermia Systems AB (publ) generates.

  • Above 15 is considered overpriced but always compare Clinical Laserthermia Systems AB (publ) to the Medical Devices industry mean.
  • A PE ratio of -1.41 means the investor is paying kr-1.41 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Clinical Laserthermia Systems AB (publ):

  • The EOD is -1.209. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.413. Based on the earnings, the company is expensive. -2
  • The TTM is -0.748. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.209MRQ-1.413+0.204
MRQ-1.413TTM-0.748-0.665
TTM-0.748YOY-0.172-0.576
TTM-0.7485Y-0.906+0.158
5Y-0.90610Y-4.803+3.897
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.209-1.069-0.140
MRQ-1.413-1.360-0.053
TTM-0.748-1.961+1.213
YOY-0.172-2.324+2.152
5Y-0.906-2.115+1.209
10Y-4.803-2.205-2.598
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Clinical Laserthermia Systems AB (publ):

  • The EOD is -1.292. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.510. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.718. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.292MRQ-1.510+0.218
MRQ-1.510TTM-0.718-0.792
TTM-0.718YOY-0.104-0.614
TTM-0.7185Y1.218-1.935
5Y1.21810Y-8.126+9.344
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.292-1.388+0.096
MRQ-1.510-1.767+0.257
TTM-0.718-2.060+1.342
YOY-0.104-5.503+5.399
5Y1.218-3.739+4.957
10Y-8.126-4.711-3.415
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Clinical Laserthermia Systems AB (publ) is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.26 means the investor is paying kr1.26 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Clinical Laserthermia Systems AB (publ):

  • The EOD is 1.077. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.259. Based on the equity, the company is underpriced. +1
  • The TTM is 0.869. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.077MRQ1.259-0.182
MRQ1.259TTM0.869+0.389
TTM0.869YOY1.933-1.063
TTM0.8695Y-6.362+7.231
5Y-6.36210Y-0.491-5.872
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.0772.148-1.071
MRQ1.2592.144-0.885
TTM0.8692.339-1.470
YOY1.9333.045-1.112
5Y-6.3624.091-10.453
10Y-0.4914.612-5.103
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Retained Earnings  36,314-19,32316,991-7,5819,410-6,0363,374-10,799-7,425



6.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in SEK. All numbers in thousands.

Summary
Total Assets68,486
Total Liabilities10,283
Total Stockholder Equity61,095
 As reported
Total Liabilities 10,283
Total Stockholder Equity+ 61,095
Total Assets = 68,486

Assets

Total Assets68,486
Total Current Assets31,328
Long-term Assets37,158
Total Current Assets
Cash And Cash Equivalents 15,581
Net Receivables 7,479
Inventory 7,259
Other Current Assets 1,009
Total Current Assets  (as reported)31,328
Total Current Assets  (calculated)31,328
+/-0
Long-term Assets
Property Plant Equipment 4,824
Intangible Assets 19,920
Long-term Assets  (as reported)37,158
Long-term Assets  (calculated)24,744
+/- 12,414

Liabilities & Shareholders' Equity

Total Current Liabilities10,060
Long-term Liabilities223
Total Stockholder Equity61,095
Total Current Liabilities
Short-term Debt 231
Accounts payable 6,173
Other Current Liabilities 3,600
Total Current Liabilities  (as reported)10,060
Total Current Liabilities  (calculated)10,004
+/- 56
Long-term Liabilities
Long-term Liabilities  (as reported)223
Long-term Liabilities  (calculated)0
+/- 223
Total Stockholder Equity
Common Stock32,176
Retained Earnings -7,425
Accumulated Other Comprehensive Income 2,323
Other Stockholders Equity 34,021
Total Stockholder Equity (as reported)61,095
Total Stockholder Equity (calculated)61,095
+/-0
Other
Cash and Short Term Investments 15,581
Common Stock Shares Outstanding 13,271
Current Deferred Revenue56
Liabilities and Stockholders Equity 68,486
Net Debt -15,350
Net Working Capital 21,268
Short Long Term Debt Total 231



6.3. Balance Sheets Structured

Currency in SEK. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-30
> Total Assets 
0
0
5,523
0
8,952
8,308
8,202
14,651
13,699
12,298
11,763
17,547
16,192
14,759
13,005
19,429
19,735
17,761
20,062
16,482
15,184
13,989
29,199
26,310
22,389
19,355
36,954
30,506
30,231
26,574
22,267
41,004
32,315
33,118
27,303
44,364
35,407
43,928
44,937
38,288
65,894
65,156
58,020
46,737
59,530
48,571
38,667
76,253
65,818
56,402
44,399
47,896
96,560
82,966
66,738
55,329
50,653
66,962
49,506
40,495
44,466
72,085
57,725
59,166
61,439
68,486
68,48661,43959,16657,72572,08544,46640,49549,50666,96250,65355,32966,73882,96696,56047,89644,39956,40265,81876,25338,66748,57159,53046,73758,02065,15665,89438,28844,93743,92835,40744,36427,30333,11832,31541,00422,26726,57430,23130,50636,95419,35522,38926,31029,19913,98915,18416,48220,06217,76119,73519,42913,00514,75916,19217,54711,76312,29813,69914,6518,2028,3088,95205,52300
   > Total Current Assets 
0
0
2,230
0
3,984
2,573
1,651
7,538
6,160
4,292
3,393
8,797
7,103
5,146
2,918
8,923
8,593
6,230
8,035
3,987
2,052
618
14,843
11,320
6,812
3,193
20,240
13,221
12,461
8,457
3,708
22,037
12,819
13,254
7,256
23,997
11,790
19,981
20,395
13,002
40,412
39,397
31,300
20,619
34,018
23,663
12,548
50,710
41,181
31,969
20,899
25,044
71,571
58,209
42,425
31,593
25,155
41,506
24,264
13,626
15,786
42,326
27,145
28,480
25,146
31,328
31,32825,14628,48027,14542,32615,78613,62624,26441,50625,15531,59342,42558,20971,57125,04420,89931,96941,18150,71012,54823,66334,01820,61931,30039,39740,41213,00220,39519,98111,79023,9977,25613,25412,81922,0373,7088,45712,46113,22120,2403,1936,81211,32014,8436182,0523,9878,0356,2308,5938,9232,9185,1467,1038,7973,3934,2926,1607,5381,6512,5733,98402,23000
       Cash And Cash Equivalents 
0
0
1,992
0
3,494
2,299
1,262
6,949
5,788
3,864
2,912
8,219
6,560
4,386
2,366
7,998
7,852
5,379
7,053
3,153
1,233
154
13,502
10,460
5,913
2,094
18,704
12,111
11,452
7,382
2,629
19,655
11,144
11,061
6,198
21,925
10,099
15,602
2,019
620
32,244
803
474
1,248
22,339
12,510
2,156
8,918
2,774
879
595
10,945
55,181
40,724
1,706
3,433
4,663
24,321
10,449
5,243
5,626
30,230
15,331
15,653
11,970
15,581
15,58111,97015,65315,33130,2305,6265,24310,44924,3214,6633,4331,70640,72455,18110,9455958792,7748,9182,15612,51022,3391,24847480332,2446202,01915,60210,09921,9256,19811,06111,14419,6552,6297,38211,45212,11118,7042,0945,91310,46013,5021541,2333,1537,0535,3797,8527,9982,3664,3866,5608,2192,9123,8645,7886,9491,2622,2993,49401,99200
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,621
7,153
85
31,584
23,951
12,249
3,605
3,605
3,605
35,027
31,024
23,545
11,276
6,062
6,062
6,062
29,459
18,250
9,955
168
139
139
139
0
0
0
0
0
000001391391391689,95518,25029,4596,0626,0626,06211,27623,54531,02435,0273,6053,6053,60512,24923,95131,584857,15313,62100000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
133
0
0
0
0
0
0
0
4
1,450
247
369
1,246
172
3,546
206
349
1,324
4,974
658
188
580
6,274
2,146
2,640
2,141
7,104
5,098
5,898
13,566
12,180
5,256
5,297
5,893
2,639
3,257
7,661
7,479
7,4797,6613,2572,6395,8935,2975,25612,18013,5665,8985,0987,1042,1412,6402,1466,2745801886584,9741,3243492063,5461721,2463692471,450400000001330000000000000000000000000000
       Other Current Assets 
0
0
238
0
490
274
389
589
372
428
481
578
542
760
552
925
741
851
982
834
818
464
1,341
860
899
1,098
1,536
1,110
0
1,075
1,079
2,382
1,675
2,193
1,058
2,072
1,691
0
4,602
2,224
4,816
3,295
0
3,711
4,741
3,916
0
5,024
5,658
5,438
1
5,395
7,690
8,785
1
6,073
6,873
1
-1
1,577
1,691
3,062
3,060
7,207
750
1,009
1,0097507,2073,0603,0621,6911,577-116,8736,07318,7857,6905,39515,4385,6585,02403,9164,7413,71103,2954,8162,2244,60201,6912,0721,0582,1931,6752,3821,0791,07501,1101,5361,0988998601,341464818834982851741925552760542578481428372589389274490023800
   > Long-term Assets 
0
0
3,294
0
4,968
5,735
6,551
7,113
7,539
8,006
8,370
8,749
9,090
9,613
10,087
10,506
11,142
11,531
12,027
12,495
13,133
13,371
14,356
14,991
15,577
16,163
16,715
17,285
17,771
18,117
18,559
18,968
19,496
19,864
20,047
20,367
23,616
23,947
24,542
25,286
25,482
25,759
26,720
26,118
25,512
24,908
26,119
25,543
24,637
24,433
23,500
22,852
24,989
24,757
24,313
23,736
25,498
25,457
25,242
26,869
28,680
29,759
30,580
30,686
36,293
37,158
37,15836,29330,68630,58029,75928,68026,86925,24225,45725,49823,73624,31324,75724,98922,85223,50024,43324,63725,54326,11924,90825,51226,11826,72025,75925,48225,28624,54223,94723,61620,36720,04719,86419,49618,96818,55918,11717,77117,28516,71516,16315,57714,99114,35613,37113,13312,49512,02711,53111,14210,50610,0879,6139,0908,7498,3708,0067,5397,1136,5515,7354,96803,29400
       Property Plant Equipment 
0
0
186
0
296
308
307
286
279
258
234
213
191
169
148
127
306
218
295
266
237
207
178
165
152
138
122
109
95
82
69
55
42
29
15
2
919
861
821
806
511
470
620
579
536
494
2,407
2,279
2,103
2,281
2,054
1,956
1,739
1,597
1,477
1,331
1,185
1,193
1,803
2,895
2,310
2,645
3,877
3,932
4,742
4,824
4,8244,7423,9323,8772,6452,3102,8951,8031,1931,1851,3311,4771,5971,7391,9562,0542,2812,1032,2792,407494536579620470511806821861919215294255698295109122138152165178207237266295218306127148169191213234258279286307308296018600
       Intangible Assets 
0
0
3,108
0
4,672
5,427
6,245
6,827
7,260
7,748
8,135
8,537
8,898
9,444
9,940
10,379
0
11,313
11,732
12,229
12,896
13,163
14,178
14,826
15,426
16,024
16,593
17,176
17,675
18,035
18,490
18,912
19,454
19,835
20,031
20,365
22,697
23,084
23,719
24,477
24,967
25,283
26,053
25,492
24,928
24,372
23,713
23,264
22,534
21,954
21,248
20,698
20,079
19,890
19,593
19,085
18,629
18,150
17,664
18,244
17,799
18,322
18,880
18,450
18,499
19,920
19,92018,49918,45018,88018,32217,79918,24417,66418,15018,62919,08519,59319,89020,07920,69821,24821,95422,53423,26423,71324,37224,92825,49226,05325,28324,96724,47723,71923,08422,69720,36520,03119,83519,45418,91218,49018,03517,67517,17616,59316,02415,42614,82614,17813,16312,89612,22911,73211,313010,3799,9409,4448,8988,5378,1357,7487,2606,8276,2455,4274,67203,10800
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,794
20,199
19,803
19,209
18,615
20,994
20,499
20,557
20,101
21,933
-1
20,959
0
23,743
0
0
0
0
0
0000023,743020,959-121,93320,10120,55720,49920,99418,61519,20919,80320,19920,79400000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
1,846
0
1,601
1,350
1,574
1,628
1,548
1,237
1,405
1,394
1,697
1,493
2,175
1,848
1,584
2,539
2,968
3,040
6,078
8,886
3,110
2,813
2,370
2,442
5,379
3,461
2,442
2,565
2,807
7,790
3,362
11,084
10,239
11,198
7,316
6,915
11,941
6,568
6,979
5,762
8,213
6,707
29,256
27,388
31,670
28,641
29,615
29,054
30,471
44,714
44,647
41,525
45,554
48,621
50,919
45,237
41,641
37,460
58,065
10,107
14,197
11,377
22,574
10,283
10,28322,57411,37714,19710,10758,06537,46041,64145,23750,91948,62145,55441,52544,64744,71430,47129,05429,61528,64131,67027,38829,2566,7078,2135,7626,9796,56811,9416,9157,31611,19810,23911,0843,3627,7902,8072,5652,4423,4615,3792,4422,3702,8133,1108,8866,0783,0402,9682,5391,5841,8482,1751,4931,6971,3941,4051,2371,5481,6281,5741,3501,60101,84600
   > Total Current Liabilities 
0
0
1,046
0
822
571
984
1,038
958
647
1,198
1,188
1,490
1,214
2,028
1,701
1,437
2,394
2,894
2,966
6,005
8,812
3,036
2,813
2,370
2,442
5,379
3,461
2,442
2,565
2,807
7,790
3,362
11,084
10,239
11,198
5,316
5,015
10,541
5,168
5,579
4,362
7,213
5,707
8,256
6,388
31,062
27,936
28,902
28,454
30,031
44,455
44,196
41,325
45,454
48,571
50,919
45,237
41,641
37,460
58,065
9,872
13,974
11,154
22,351
10,060
10,06022,35111,15413,9749,87258,06537,46041,64145,23750,91948,57145,45441,32544,19644,45530,03128,45428,90227,93631,0626,3888,2565,7077,2134,3625,5795,16810,5415,0155,31611,19810,23911,0843,3627,7902,8072,5652,4423,4615,3792,4422,3702,8133,0368,8126,0052,9662,8942,3941,4371,7012,0281,2141,4901,1881,1986479581,03898457182201,04600
       Short-term Debt 
0
0
13
0
0
0
160
120
80
15
333
250
167
83
133
88
43
0
33
0
1,789
3,000
74
0
0
0
74
0
0
0
74
0
0
0
74
0
0
0
474
300
200
100
474
300
200
100
474
300
200
100
474
300
200
100
174
50
0
0
30,678
28,735
45,115
1,776
231
231
231
231
2312312312311,77645,11528,73530,6780050174100200300474100200300474100200300474100200300474000740007400074000743,0001,789033043881338316725033315801201600001300
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300
200
100
474
300
200
100
174
50
0
0
30,678
0
0
0
0
0
0
0
000000030,678005017410020030047410020030000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
825
0
503
217
602
821
690
344
489
766
965
971
1,220
739
541
1,609
2,047
2,348
3,637
3,067
2,062
2,128
1,666
1,866
4,177
2,552
1,467
1,644
1,641
4,602
2,285
4,278
2,766
6,164
2,798
3,528
2,764
2,890
2,782
2,314
4,997
3,758
3,599
4,123
7,446
4,579
5,539
5,196
4,460
5,261
5,190
2,599
4,314
4,921
5,285
4,713
5,934
3,389
4,495
5,566
9,168
6,623
5,327
6,173
6,1735,3276,6239,1685,5664,4953,3895,9344,7135,2854,9214,3142,5995,1905,2614,4605,1965,5394,5797,4464,1233,5993,7584,9972,3142,7822,8902,7643,5282,7986,1642,7664,2782,2854,6021,6411,6441,4672,5524,1771,8661,6662,1282,0623,0673,6372,3482,0471,6095417391,220971965766489344690821602217503082500
       Other Current Liabilities 
0
0
0
0
319
353
0
0
0
0
0
0
2
58
45
38
44
785
65
618
140
1,582
974
685
704
576
77
909
976
922
111
3,188
1,077
6,806
88
5,033
2,518
1,487
116
320
234
388
228
324
1,101
396
20,260
20,211
20,275
20,468
20,227
35,300
35,504
35,507
35,877
43,600
45,634
40,524
5,029
34,071
53,570
4,306
4,398
1,392
13,664
3,600
3,60013,6641,3924,3984,30653,57034,0715,02940,52445,63443,60035,87735,50735,50435,30020,22720,46820,27520,21120,2603961,1013242283882343201161,4872,5185,033886,8061,0773,188111922976909775767046859741,582140618657854438455820000003533190000
   > Long-term Liabilities 
0
0
800
0
779
779
590
590
590
590
207
207
207
279
147
147
147
145
74
74
74
74
74
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000
1,900
1,400
1,400
1,400
1,400
1,000
1,000
21,000
21,000
608
705
713
600
440
259
451
200
100
50
5,285
4,713
36,612
3,389
0
235
223
223
223
223
22322322322323503,38936,6124,7135,2855010020045125944060071370560821,00021,0001,0001,0001,4001,4001,4001,4001,9002,00000000000000007474747474145147147147279207207207590590590590779779080000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
105
113
0
240
59
251
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000025159240011310500000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,794
20,199
19,605
19,011
18,417
17,823
17,229
17,313
16,781
16,249
15,717
15,184
0
15,172
0
0
0
0
0
0000015,172015,18415,71716,24916,78117,31317,22917,82318,41719,01119,60520,19920,79400000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
3,678
0
7,351
6,958
6,629
13,023
12,151
11,061
10,358
16,152
14,495
13,267
10,831
17,582
18,151
15,222
17,094
13,442
9,106
5,103
26,090
23,497
20,019
16,913
31,576
27,045
27,789
24,009
19,460
33,214
28,953
22,035
17,064
33,166
28,091
37,013
32,996
31,720
58,915
59,394
49,807
40,030
30,274
21,183
6,997
47,612
36,203
27,348
13,928
3,182
51,913
41,039
21,794
7,487
626
22,959
9,217
4,565
-11,968
64,053
45,769
50,689
41,738
61,095
61,09541,73850,68945,76964,053-11,9684,5659,21722,9596267,48721,79441,03951,9133,18213,92827,34836,20347,6126,99721,18330,27440,03049,80759,39458,91531,72032,99637,01328,09133,16617,06422,03528,95333,21419,46024,00927,78927,04531,57616,91320,01923,49726,0905,1039,10613,44217,09415,22218,15117,58210,83113,26714,49516,15210,35811,06112,15113,0236,6296,9587,35103,67800
   Common Stock
0
0
571
0
643
643
643
897
897
897
904
1,019
1,019
1,019
1,019
1,214
1,271
1,273
1,347
1,347
1,347
1,347
1,577
1,577
1,577
1,577
1,577
1,817
1,876
1,876
1,876
2,165
2,192
2,200
2,200
2,514
2,514
2,514
2,654
2,654
3,117
3,201
3,201
3,201
3,209
3,209
3,209
4,205
4,205
4,205
4,205
4,205
6,013
6,079
6,089
6,089
6,411
11,540
12,050
15,063
15,063
15,425
15,425
18,134
18,134
32,176
32,17618,13418,13415,42515,42515,06315,06312,05011,5406,4116,0896,0896,0796,0134,2054,2054,2054,2054,2053,2093,2093,2093,2013,2013,2013,1172,6542,6542,5142,5142,5142,2002,2002,1922,1651,8761,8761,8761,8171,5771,5771,5771,5771,5771,3471,3471,3471,3471,2731,2711,2141,0191,0191,0191,019904897897897643643643057100
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
209
-21
14
2
9
9
-20
-23
-160
-4
166
399
136
3,461
-470
-238
-278
-131
32
-591
286
-905
686
781
2,359
3,315
3,758
3,716
3,395
3,588
2,973
2,043
1,907
3,046
2,804
2,516
3,555
2,396
2,377
2,323
2,3232,3772,3963,5552,5162,8043,0461,9072,0432,9733,5883,3953,7163,7583,3152,359781686-905286-59132-131-278-238-4703,461136399166-4-160-23-2099214-2120900000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
3,933
0
8,790
8,790
8,790
16,798
16,806
16,806
17,211
24,564
24,564
24,564
24,564
34,503
37,471
37,612
43,196
43,196
43,196
43,196
70,287
70,287
70,287
70,287
93,406
93,385
97,846
97,846
97,846
119,404
121,358
122,236
122,099
145,724
145,728
160,998
161,826
158,567
204,310
212,551
213,285
213,432
214,280
213,690
213,753
274,146
274,919
274,787
274,655
270,436
337,055
339,839
339,828
339,800
351,651
401,967
405,957
11,827
11,827
9,798
9,798
20,749
17,853
34,021
34,02117,85320,7499,7989,79811,82711,827405,957401,967351,651339,800339,828339,839337,055270,436274,655274,787274,919274,146213,753213,690214,280213,432213,285212,551204,310158,567161,826160,998145,728145,724122,099122,236121,358119,40497,84697,84697,84693,38593,40670,28770,28770,28770,28743,19643,19643,19643,19637,61237,47134,50324,56424,56424,56424,56417,21116,80616,80616,7988,7908,7908,79003,93300



6.4. Balance Sheets

Currency in SEK. All numbers in thousands.




6.5. Cash Flows

Currency in SEK. All numbers in thousands.




6.6. Income Statements

Currency in SEK. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in SEK. All numbers in thousands.

Gross Profit (+$)
totalRevenue8,273
Cost of Revenue-5,276
Gross Profit2,9972,997
 
Operating Income (+$)
Gross Profit2,997
Operating Expense-68,478
Operating Income-65,933-65,481
 
Operating Expense (+$)
Research Development2,130
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense68,4782,130
 
Net Interest Income (+$)
Interest Income4
Interest Expense-9,760
Other Finance Cost-1,481
Net Interest Income-11,238
 
Pretax Income (+$)
Operating Income-65,933
Net Interest Income-11,238
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-80,875-50,991
EBIT - interestExpense = -80,874
-80,875
-70,032
Interest Expense9,760
Earnings Before Interest and Taxes (EBIT)-71,114-71,115
Earnings Before Interest and Taxes (EBITDA)-68,406
 
After tax Income (+$)
Income Before Tax-80,875
Tax Provision-0
Net Income From Continuing Ops-64,300-80,875
Net Income-79,792
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses74,109
Total Other Income/Expenses Net-14,94211,238
 

Technical Analysis of Clinical Laserthermia Systems AB (publ)
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Clinical Laserthermia Systems AB (publ). The general trend of Clinical Laserthermia Systems AB (publ) is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Clinical Laserthermia Systems AB (publ)'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Clinical Laserthermia Systems AB (publ).

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 4.4005 < 6.2 < 6.4.

The bearish price targets are: .

Tweet this
Clinical Laserthermia Systems AB (publ) Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Clinical Laserthermia Systems AB (publ). The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Clinical Laserthermia Systems AB (publ) Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Clinical Laserthermia Systems AB (publ). The current macd is -0.32029836.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Clinical Laserthermia Systems AB (publ) price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Clinical Laserthermia Systems AB (publ). This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Clinical Laserthermia Systems AB (publ) price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Clinical Laserthermia Systems AB (publ) Daily Moving Average Convergence/Divergence (MACD) ChartClinical Laserthermia Systems AB (publ) Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Clinical Laserthermia Systems AB (publ). The current adx is 18.20.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Clinical Laserthermia Systems AB (publ) shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Clinical Laserthermia Systems AB (publ) Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Clinical Laserthermia Systems AB (publ). The current sar is 3.6.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Clinical Laserthermia Systems AB (publ) Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Clinical Laserthermia Systems AB (publ). The current rsi is 49.35. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Clinical Laserthermia Systems AB (publ) Daily Relative Strength Index (RSI) ChartClinical Laserthermia Systems AB (publ) Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Clinical Laserthermia Systems AB (publ). The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Clinical Laserthermia Systems AB (publ) price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Clinical Laserthermia Systems AB (publ) Daily Stochastic Oscillator ChartClinical Laserthermia Systems AB (publ) Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Clinical Laserthermia Systems AB (publ). The current cci is -39.3721179.

Clinical Laserthermia Systems AB (publ) Daily Commodity Channel Index (CCI) ChartClinical Laserthermia Systems AB (publ) Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Clinical Laserthermia Systems AB (publ). The current cmo is 7.72474242.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Clinical Laserthermia Systems AB (publ) Daily Chande Momentum Oscillator (CMO) ChartClinical Laserthermia Systems AB (publ) Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Clinical Laserthermia Systems AB (publ). The current willr is -55.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Clinical Laserthermia Systems AB (publ) is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Clinical Laserthermia Systems AB (publ) Daily Williams %R ChartClinical Laserthermia Systems AB (publ) Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Clinical Laserthermia Systems AB (publ).

Clinical Laserthermia Systems AB (publ) Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Clinical Laserthermia Systems AB (publ). The current atr is 0.52511541.

Clinical Laserthermia Systems AB (publ) Daily Average True Range (ATR) ChartClinical Laserthermia Systems AB (publ) Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Clinical Laserthermia Systems AB (publ). The current obv is -561,735.

Clinical Laserthermia Systems AB (publ) Daily On-Balance Volume (OBV) ChartClinical Laserthermia Systems AB (publ) Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Clinical Laserthermia Systems AB (publ). The current mfi is 21.89.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Clinical Laserthermia Systems AB (publ) Daily Money Flow Index (MFI) ChartClinical Laserthermia Systems AB (publ) Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Clinical Laserthermia Systems AB (publ).

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-26MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Clinical Laserthermia Systems AB (publ) Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Clinical Laserthermia Systems AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.351
Ma 20Greater thanMa 504.604
Ma 50Greater thanMa 1004.910
Ma 100Greater thanMa 2005.223
OpenGreater thanClose3.820
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Clinical Laserthermia Systems AB (publ) with someone you think should read this too:
  • Are you bullish or bearish on Clinical Laserthermia Systems AB (publ)? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Clinical Laserthermia Systems AB (publ)? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Clinical Laserthermia Systems AB (publ)

I send you an email if I find something interesting about Clinical Laserthermia Systems AB (publ).


Comments

How you think about this?

Leave a comment

Stay informed about Clinical Laserthermia Systems AB (publ).

Receive notifications about Clinical Laserthermia Systems AB (publ) in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.